WHO comparator product list is a reference database for equivalence study of generic drug product to get the respective market authorization.
Generic Name - Comparator Product - Market
- Kanamycin - Kanamycin sulfate – US market
- Ketamine – Ketalar – US market
- Lactulose – Lactulose – US market
- Lamivudine (3TC) – Epivir – SRA market
- Lamivudine + nevirapine + stavudine – Monocomponents – SRA market
- Lamivudine + zidovudine – Combivir – SRA market
- Latanoprost – Xalatan - SRA market
- Levamisole – Ascaridil, Decaris – Brazil, Mexico market
- Levodopa + carbidopa – Sinemet – SRA market
- Levofloxacin – Tavanic, Levaquin – EU, US market
- Levonorgestrel – Microval, Microlut, Postinor-2, Postinor-1, Plan B One-Step – France, Germany, EU, US market
- Levonorgestrel-releasing implant – Jadelle – EU market
- Levothyroxine – Euthyrox, Synthroid – EU, US market
- Lidocaine - Xylocaine – US market
- Lidocaine + epinephrine (adrenaline) - Xylocaine w/ Epinephrine – US market
- Lithium carbonate - Lithium carbonate, Carbolith – US, Canada market
- Loperamide – Imodium – EU, US market
- Lopinavir + ritonavir (LPV/r) – Kaletra – US, UK, SRA market
- Loratadine – Claritin – US, SRA market
- Lorazepam – Ativan – US market
- Magnesium sulfate - Magnesium sulfate 500 mg/ml – US market
- Mebendazole – Vermox – EU market
- Medroxyprogesterone acetate – Provera – US market
- Mefloquine – Lariam, Mefloquine HCl – EU, US market
- Mercaptopurine – Mercaptopurine tablet – US market
- Mesna – Mesnex – US market
- Metformin – Glucophage – EU, US market
- Methadone - Methadone Hydrochloride – US market
- Methadone – Methadose – US market
- Methotrexate - Methotrexate sodium – US, SRA market
- Methyldopa – Aldomet, Methyldopa – UK, US market
- Methylprednisolone - Depo-Medrol – SRA market
- Metoclopramide – Reglan – US market
- Metoclopramide - Metoclopramide HCl – US market
- Metronidazole – Flagyl – US, UK market
- Miconazole – Daktarin – EU market
- Midazolam - Dormicum – EU market
- Midazolam - Midazolam HCl – US market
- Midazolam - Buccolam – EU market
- Mifepristone + misoprostol - Mifegyne (mifepristone) Cytotec (misoprostol) - UK, EU, USA market
- Miltefosine – Impavido – US market
- Misoprostol – Cytotec – EU, US market
- Morphine - Morphine sulfate – US market
- Morphine - MS Contin – US market
- Mupirocin – Bactroban – SRA market
- Naloxone - Naloxone hydrochloride – US market
- Neostigmine – Prostigmin – EU market
- Nevirapine (NVP) – Viramune – SRA market
- Niclosamide – Yomesan – Germany market
- Nicotinamide - Nicontinamide 100 mg tablet – UK market
- Nicotine replacement therapy (NRT) – Nicotinell, Nicorette – SRA market
- Nifedipine – Adalat, Procardia – EU, US market
- Nitrofurantoin - Macrodantin (capsules) – US market
- Nitrofurantoin - Furadantin (oral suspension) – EU, US market
- Norethisterone enantate – Noristerat – EU market
- Nystatin – Nystatin Susp. Tab. – US, EU market
Previous: WHO Comparator Product Database (F - J)
Note:
SRA = Stringent Regulatory Authorities
EU = European Union
USA = United States of America
UK = United Kingdom
Tags in: who list of international comparator products, who comparator drug, who recommended comparator.